Leprosy - an overview of clinical features, diagnosis, and treatment

Area of Science:

• Infectious Diseases
• Dermatology
• Neurology

Background:

• Leprosy is a chronic infectious disease caused by Mycobacterium leprae, with over 210,000 new cases globally in 2015.
• Transmission is likely via nasal droplets, primarily affecting the skin and peripheral nervous system.
• Disease presentation varies from paucibacillary tuberculoid to multibacillary lepromatous forms, influenced by host immunity.

Purpose of the Study:

• To provide an overview of leprosy, including its epidemiology, clinical manifestations, and current treatment guidelines.
• To highlight the importance of early diagnosis and treatment for complete remission.
• To emphasize the role of preventive measures in endemic regions.

Main Methods:

• Review of current medical literature and World Health Organization (WHO) recommendations on leprosy.
• Description of clinical classifications and diagnostic features.
• Outline of treatment regimens for different leprosy forms.

Main Results:

• Early treatment of paucibacillary leprosy involves rifampicin and dapsone for at least six months.
• Multibacillary leprosy requires a 12-month regimen including clofazimine, rifampicin, and dapsone.
• Leprosy reactions can complicate treatment, necessitating management alongside standard therapy.

Conclusions:

• Early and appropriate multidrug therapy leads to remission and prevents sequelae.
• Preventive strategies supported by the WHO are essential in leprosy-endemic areas.
• Continued research and public health initiatives are vital for leprosy control and elimination.